Selected article for: "immunosuppressive therapy and infection risk"
Author: Ridruejo, Ezequiel; Soza, Alejandro
Title: The liver in times of COVID-19: What hepatologists should know
  • Cord-id: ovb7fweb
  • Document date: 2020_5_18
    • ID: ovb7fweb
    Snippet: The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis a
    Document: The ongoing pandemic of coronavirus disease 2019 (COVID-19) pandemic poses a serious threat to healthcare systems globally. Information regarding to the how the infection affects the liver and relevance of pre-existing liver disease as a risk factor for acquiring the infection or having a severe disease are still scarce. Also, considerations to be considered in liver transplant patients or those having hepatocellular carcinoma or are under immunosuppressive therapy are being matter of analysis as information is being generated. Different treatments for COVID-19 are currently under study some of which may be associated to hepatotoxicity. In the present review we discuss current data on the COVID-19 and liver aiming to provide hepatologists with updated information to face this pandemic.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and admission avoid: 1
    • acute ards respiratory distress syndrome and admit patient: 1
    • acute ards respiratory distress syndrome and adrenal insufficiency: 1, 2, 3
    • acute ards respiratory distress syndrome and liver affect: 1, 2
    • acute ards respiratory distress syndrome and liver cell: 1, 2
    • acute ards respiratory distress syndrome and liver damage: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute ards respiratory distress syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acute ards respiratory distress syndrome and liver disease patient: 1
    • acute ards respiratory distress syndrome and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute ards respiratory distress syndrome and liver enzyme: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
    • acute ards respiratory distress syndrome and liver injury cause: 1
    • acute ards respiratory distress syndrome and liver tissue: 1, 2, 3
    • acute ards respiratory distress syndrome and liver transplant: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and liver transplantation: 1, 2, 3
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • acute ards respiratory distress syndrome patient and liver injury: 1
    • acute ards respiratory distress syndrome patient and lopinavir ritonavir: 1